Agios Pharmaceuticals Inc. buy Citigroup Inc.
Start price
26.12.25
/
50%
€23.80
Target price
26.12.26
-
Performance (%)
22.69%
Price
13.08.26
€29.20
Summary
This prediction is currently active. The prediction currently has a performance of 22.69%. This prediction currently runs until 26.12.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | 5.036% | 5.036% |
| iShares Core DAX® | 0.881% | 5.632% |
| iShares Nasdaq 100 | 2.390% | 1.571% |
| iShares Nikkei 225® | 4.269% | 2.521% |
| iShares S&P 500 | 1.171% | 2.545% |
Comments by Citigroup_Inc_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (NASDAQ:AGIO) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€24.00
05.03.26
05.03.26
€39.57
05.03.27
05.03.27
21.67%
13.08.26
13.08.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.20
29.11.25
29.11.25
-
29.11.26
29.11.26
15.87%
13.08.26
13.08.26

